CAR19 T cells carrying cytoplasmic activated PD-1: Clinical Trials

1 trial of CAR19 T cells carrying cytoplasmic activated PD-1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1

Follow CAR19 T cells carrying cytoplasmic activated PD-1: new trials by email Literature Review of CAR19 T cells carrying cytoplasmic activated PD-1 trials Research Report on CAR19 T cells carrying cytoplasmic activated PD-1

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cytoplasmic Activated PD-1 CAR T Cells in Refractory/Relapsed B Cell Lymphoma
CAR19 T cells carrying cytoplasmic activated PD-1 - Relapsed Non Hodgkin Lymphoma
Phase 1UnknownHenan Cancer Hospital152018-04-122018-05-30

Conditions studied

Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Recurrence (1)

Sponsors

Henan Cancer Hospital (1)

Countries

China (1)

Top investigators

Yongping Song, M.D (1)